Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
TBC Novartis Pharmaceuticals Australia Pty Ltd
Product name
TBC
Accepted date
Oct-2023
Active ingredients
ribociclib succinate
Proposed indication
Is indicated for the adjuvant treatment of patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative stage II and III early breast cancer.
Application type
C (new indication)
Publication date
Oct-2023